Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis

Marco Solmi, G Giorgio Pigato, Beatrice Roiter, Argentina Guaglianone, Luca Martini, Michele Fornaro, Francesco Monaco, Andrè F Carvalho, Brendon Stubbs, Nicola Veronese, Christoph U Correll, Marco Solmi, G Giorgio Pigato, Beatrice Roiter, Argentina Guaglianone, Luca Martini, Michele Fornaro, Francesco Monaco, Andrè F Carvalho, Brendon Stubbs, Nicola Veronese, Christoph U Correll

Abstract

Catatonia is an independent syndrome that co-occurs with several mental and medical conditions. We performed a systematic literature review in PubMed/Scopus until February 2017 and meta-analyzed studies reporting catatonia prevalence. Across 74 studies (cross-sectional = 32, longitudinal = 26, retrospective = 16) providing data collected from 1935 to 2017 across all continents, mean catatonia prevalence was 9.0% (k = 80, n = 110764; 95% CI = 6.9-11.7, I2 = 98%, publication bias P < .01), decreasing to 7.8% (k = 19, n = 7612, 95% CI = 7-8.7, I2 = 38.9%) in a subgroup with low heterogeneity. Catatonia prevalence was 23.9% (k = 8, n = 1168, 95% CI = 10-46.9, I2 = 96%) in patients undergoing ECT/having elevated creatinine phosphokinase. Excluding ECT samples, the catatonia prevalence was 8.1% (k = 72, n = 109606, 95% CI = 6.1-10.5, I2 = 98%, publication bias P < .01), with sensitivity analyses demonstrating that country of study origin (P < .001), treatment setting (P = .003), main underlying condition (P < .001), and sample size (P < .001)moderated catatonia prevalence, being highest in Uganda (48.5%, k = 1) and lowest in Mexico (1.9%, 95% CI = 0.4-8.8, I2 = 67%, k = 2), highest in nonpsychiatric out- or inpatient services (15.8%, 95% CI = 8.1-28.4, I2 = 97%, k = 15)and lowest in psychiatric outpatients services (3.2%, 95% CI = 1.7-6.1, I2 = 50%, k = 3), highest in presence of medical or neurological illness with no comorbid psychiatric condition (20.6%, 95% CI = 11.5-34.2, I2 = 95%, k = 10)and lowest in mixed psychiatric samples (5.7%, 95% CI = 4.2-7.7, I2 =98%, k = 43), highest in studies with sample sizes <100 (20.7%, 95% CI = 12.8-31.6, I2 = 90%, k = 17) and lowest in studies with sample sizes >1000 (2.3%, 95% CI = 1.3-3.9, I2 = 99%, k = 16). Meta-regression showed that smaller sample size (P < .01) and less major depressive disorder (P = .02) moderated higher catatonia prevalence. Year of data collection did not significantly moderate the results. Results from this first meta-analysis of catatonia frequencies across time and disorders suggest that catatonia is an epidemiologically and clinically relevant condition that occurs throughout several mental and medical conditions, whose prevalence has not decreased over time and does not seem to depend on different rating scales/criteria. However, results were highly heterogeneous, calling for a cautious interpretation.

Figures

Fig. 1.
Fig. 1.
PRISMA flowchart.
Fig. 2.
Fig. 2.
Funnel plot of meta-analysis of catatonia prevalence in whole included clinical populations (80 samples from 74 studies).
Fig. 3.
Fig. 3.
Forest plot of catatonia prevalence in a subgroup of 19 studies with reduced heterogeneity (I2 < 50%).

References

    1. Fornaro M. Catatonia: a narrative review. Cent Nerv Syst Agents Med Chem. 2011;11:73–79.
    1. Brenner I, Rheuban WJ. The catatonic dilemma. Am J Psychiatry. 1978;135:1242–1243.
    1. Penland HR, Weder N, Tampi RR. The catatonic dilemma expanded. Ann Gen Psychiatry. 2006;5:14.
    1. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996;93:129–136.
    1. Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 1):I8–I13.
    1. Francis A, Fink M, Appiani F et al. . Catatonia in diagnostic and statistical manual of mental disorders, Fifth edition. J ECT. 2010;26:246–247.
    1. Heckers S, Tandon R, Bustillo J. Catatonia in the DSM—shall we move or not?Schizophr Bull. 2010;36:205–207.
    1. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin’s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010;36:314–320.
    1. Tandon R, Heckers S, Bustillo J et al. . Catatonia in DSM-5. Schizophr Res. 2013;150:26–30.
    1. Fink MTM. Catatonia. A Clinician’s Guide to Diagnosis and Treatment. UK: Cambridge University Press. 2003.
    1. Fink M, Taylor MA. The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry. 2009;66:1173–1177.
    1. Fink M. Catatonia: a syndrome appears, disappears, and is rediscovered. Can J Psychiatry. 2009;54:437–445.
    1. Caroff SN MS, Campbell EC, Sullivan KA.. Catatonia: From Psychopathology to Neurobiology. USA: American Psychiatric Publishing. 2004.
    1. Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016;6:391–398.
    1. Ungvari GS, Goggins W, Leung SK, Lee E, Gerevich J. Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’) III. Latent class analysis of the catatonic syndrome. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:81–85.
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed Washington, DC: American Psychiatric Association; 2013.
    1. Caroff SN, Hurford I, Lybrand J, Campbell EC. Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial. Neurol Clin. 2011;29:127–148, viii.
    1. Solmi M, Murru A, Pacchiarotti I et al. . Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Ther Clin Risk Manag. 2017;13:757–777.
    1. Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia?Compr Psychiatry. 2002;43:167–174.
    1. van der Heijden FM, Tuinier S, Arts NJ, Hoogendoorn ML, Kahn RS, Verhoeven WM. Catatonia: disappeared or under-diagnosed?Psychopathology. 2005;38:3–8.
    1. Grover S, Chakrabarti S, Ghormode D, Agarwal M, Sharma A, Avasthi A. Catatonia in inpatients with psychiatric disorders: a comparison of schizophrenia and mood disorders. Psychiatry Res. 2015;229:919–925.
    1. Sienaert P, Rooseleer J, De Fruyt J. Measuring catatonia: a systematic review of rating scales. J Affect Disord. 2011;135:1–9.
    1. McKenna PJ, Lund CE, Mortimer AM, Biggins CA. Motor, volitional and behavioural disorders in schizophrenia. 2: The ‘conflict of paradigms’ hypothesis. Br J Psychiatry. 1991;158:328–336.
    1. Lund CE, Mortimer AM, Rogers D, McKenna PJ. Motor, volitional and behavioural disorders in schizophrenia. 1: Assessment using the Modified Rogers Scale. Br J Psychiatry. 1991;158:323–327, 333.
    1. Starkstein SE, Petracca G, Tesón A et al. . Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry. 1996;60:326–332.
    1. Northoff G, Koch A, Wenke J et al. . Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord. 1999;14:404–416.
    1. Bräunig P, Krüger S, Shugar G, Höffler J, Börner I. The catatonia rating scale I—development, reliability, and use. Compr Psychiatry. 2000;41:147–158.
    1. Carroll BT, Kirkhart R, Ahuja N et al. . Katatonia: a new conceptual understanding of catatonia and a new rating scale. Psychiatry (Edgmont). 2008;5:42–50.
    1. Sarkar S, Sakey S, Mathan K, Bharadwaj B, Kattimani S, Rajkumar RP. Assessing catatonia using four different instruments: inter-rater reliability and prevalence in inpatient clinical population. Asian J Psychiatr. 2016;23:27–31.
    1. Morrison JR. Catatonia: prediction of outcome. Compr Psychiatry. 1974;15:317–324.
    1. Stübner S, Rustenbeck E, Grohmann R et al. . Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry. 2004;37(suppl 1):S54–S64.
    1. Stroup DF, Berlin JA, Morton SC et al. . Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–2012.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–341.
    1. Wells GASB, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses . Accessed July 1, 2017.
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
    1. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101.
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
    1. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463.
    1. Baran B, Bitter I, Ungvari GS, Gazdag G. The birth of convulsive therapy revisited: a reappraisal of László Meduna’s first cohort of patients. J Affect Disord. 2012;136:1179–1182.
    1. Flekkoy K. Changes of associative performance in hospitalized schizophrenics: a 16-year follow-up. Acta Psychiatr Scand. 1975;52:330–335.
    1. Guggenheim FG, Babigian HM. Catatonic schizophrenia: epidemiology and clinical course. A 7-year register study of 798 cases. J Nerv Ment Dis. 1974;158:291–305.
    1. Kimura S, Asai S, Wakeno M, Aoki N. On early and mid-adolescent schizophrenia. Part 1: phenomenological aspects. Folia Psychiatr Neurol Jpn. 1978;32:41–56.
    1. Kleinhaus K, Harlap S, Perrin MC et al. . Catatonic schizophrenia: a cohort prospective study. Schizophr Bull. 2012;38:331–337.
    1. Petho B, Tolna J, Tusnády G et al. . The predictive validity of the Leonhardean classification of endogenous psychoses: a 21–33-year follow-up of a prospective study (“BUDAPEST 2000”). Eur Arch Psychiatry Clin Neurosci. 2008;258:324–334.
    1. Bland RC. Demographic aspects of functional psychoses in Canada. Acta Psychiatr Scand. 1977;55:369–380.
    1. Scharfetter C. Schizophrenia’s classical subtypes. A family heredity study. Arch Psychiatr Nervenkr (1970). 1982;231:443–447.
    1. Serban G. Stress in schizophrenics and normals. Br J Psychiatry. 1975;126:397–407.
    1. Tsoi WF. First admission schizophrenia: clinical manifestation and subtypes. Singapore Med J. 1993;34:399–402.
    1. Strian F, Klicpera C. Anxiety in schizophrenic psychoses. Arch Psychiatr Nervenkr (1970). 1983;233:347–357.
    1. Ihezue UH, Kumaraswamy N. A psychosocial study of schizophrenic patients treated at a Nigerian psychiatric hospital. J Natl Med Assoc. 1984;76:617–621.
    1. Beckmann H, Franzek E, Stöber G. Genetic heterogeneity in catatonic schizophrenia: a family study. Am J Med Genet. 1996;67:289–300.
    1. Northoff G, Wenke J, Demisch L, Eckert J, Gille B, Pflug B. Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacology (Berl). 1995;122:182–186.
    1. Beratis S, Gabriel J, Hoidas S. Gender differences in the frequency of schizophrenic subtypes in unselected hospitalized patients. Schizophr Res. 1997;23:239–244.
    1. Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry. 2000;176:357–362.
    1. Peralta V, Cuesta MJ, Mata I, Serrano JF, Perez-Nievas F, Natividad MC. Serum iron in catatonic and noncatatonic psychotic patients. Biol Psychiatry. 1999;45:788–790.
    1. Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry. 1998;44:499–507.
    1. Stein D, Kurtsman L, Stier S, Remnik Y, Meged S, Weizman A. Electroconvulsive therapy in adolescent and adult psychiatric inpatients—a retrospective chart design. J Affect Disord. 2004;82:335–342.
    1. Lykouras L, Oulis P, Daskalopoulou E, Psarros K, Christodoulou GN. Clinical subtypes of schizophrenic disorders: a cluster analytic study. Psychopathology. 2001;34:23–28.
    1. Stompe T, Ortwein-Swoboda G, Ritter K, Marquart B, Schanda H. The impact of diagnostic criteria on the prevalence of schizophrenic subtypes. Compr Psychiatry. 2005;46:433–439.
    1. Bräunig P, Krüger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry. 1998;39:35–46.
    1. Northoff G, Pfennig A, Krug M et al. . Delayed onset of late movement-related cortical potentials and abnormal response to lorazepam in catatonia. Schizophr Res. 2000;44:193–211.
    1. Lee JWY. Neuroleptic-induced catatonia. J Clin Psychopharmacol. 2010;30:3–10.
    1. Raffin M, Zugaj-Bensaou L, Bodeau N et al. . Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry. 2015;24:441–449.
    1. Conca A, Bertsch E, Küng A et al. . Zuclopenthixol-acetate treatment in catatonic patients: the implication of iron metabolism. Eur Psychiatry. 2003;18:28–31.
    1. Northoff G, Nagel D, Danos P, Leschinger A, Lerche J, Bogerts B. Impairment in visual-spatial function in catatonia: a neuropsychological investigation. Schizophr Res. 1999;37:133–147.
    1. Cohen D, Nicolas JD, Flament MF et al. . Clinical relevance of chronic catatonic schizophrenia in children and adolescents: evidence from a prospective naturalistic study. Schizophr Res. 2005;76:301–308.
    1. Krüger S, Bräunig P, Höffler J, Shugar G, Börner I, Langkrär J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000;12:16–24.
    1. Koch M, Chandragiri S, Rizvi S, Petrides G, Francis A. Catatonic signs in neuroleptic malignant syndrome. Compr Psychiatry. 2000;41:73–75.
    1. Bark R, Dieckmann S, Bogerts B, Northoff G. Deficit in decision making in catatonic schizophrenia: an exploratory study. Psychiatry Res. 2005;134:131–141.
    1. Stöber G. Genetic predisposition and environmental causes in periodic and systematic catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251(suppl 1):I21–I24.
    1. Tuerlings JH, van Waarde JA, Verwey B. A retrospective study of 34 catatonic patients: analysis of clinical care and treatment. Gen Hosp Psychiatry. 2010;32:631–635.
    1. Peralta V, Cuesta MJ. Motor features in psychotic disorders. II. Development of diagnostic criteria for catatonia. Schizophr Res. 2001;47:117–126.
    1. Consoli A, Raffin M, Laurent C et al. . Medical and developmental risk factors of catatonia in children and adolescents: a prospective case–control study. Schizophr Res. 2012;137:151–158.
    1. Gazdag G, Kocsis-Ficzere N, Tolna J. The augmentation of clozapine treatment with electroconvulsive therapy. Ideggyogy Sz. 2006;59:261–267.
    1. Krüger S, Cooke RG, Spegg CC, Bräunig P. Relevance of the catatonic syndrome to the mixed manic episode. J Affect Disord. 2003;74:279–285.
    1. Ungvari GS, Leung SK, Ng FS, Cheung HK, Leung T. Schizophrenia with prominent catatonic features (‘catatonic schizophrenia’): I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:27–38.
    1. Suzuki K, Awata S, Takano T, Ebina Y, Iwasaki H, Matsuoka H. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Psychiatry Clin Neurosci. 2005;59:481–489.
    1. Benarous X, Consoli A, Raffin M et al. . Validation of the Pediatric Catatonia Rating Scale (PCRS). Schizophr Res. 2016;176:378–386.
    1. Narayanaswamy JC, Tibrewal P, Zutshi A, Srinivasaraju R, Math SB. Clinical predictors of response to treatment in catatonia. Gen Hosp Psychiatry. 2012;34:312–316.
    1. Grover S, Ghosh A, Ghormode D. Do patients of delirium have catatonic features? An exploratory study. Psychiatry Clin Neurosci. 2014;68:644–651.
    1. Cavanna AE, Robertson MM, Critchley HD. Catatonic signs in Gilles de la Tourette syndrome. Cogn Behav Neurol. 2008;21:34–37.
    1. Chalasani P, Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med. 2005;35:1667–1675.
    1. Dutt A, Grover S, Chakrabarti S, Avasthi A, Kumar S. Phenomenology and treatment of Catatonia: a descriptive study from north India. Indian J Psychiatry. 2011;53:36–40.
    1. Ghaziuddin N, Dhossche D, Marcotte K. Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand. 2012;125:33–38.
    1. Sayegh AA, Reid D. Prevalence of catatonic signs in acute psychiatric patients in Scotland. The Psychiatrist. 2010;34:479–484.
    1. Cottencin O, Warembourg F, de Chouly de Lenclave MB et al. . Catatonia and consultation-liaison psychiatry study of 12 cases. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1170–1176.
    1. Mustafa M, Bassim R, Meguid M, Sultan M, Al Dardiry M. Ethnic differences in the prevalence of catatonia among hospitalized psychiatric patients in Kuwait. Middle East Current Psychiatry. 2012;19:214–221.
    1. Kruse JL, Lapid MI, Lennon VA et al. . Psychiatric autoimmunity: N-Methyl-D-aspartate receptor IgG and beyond. Psychosomatics. 2015;56:227–241.
    1. Yoshimura B, Hirota T, Takaki M, Kishi Y. Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients. Neuropsychiatr Dis Treat. 2013;9:1565–1571.
    1. Peralta V, Campos MS, de Jalon EG, Cuesta MJ. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Schizophr Res. 2010;118:168–175.
    1. Peralta V, Campos MS, De Jalón EG, Cuesta MJ. Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders. Mov Disord. 2010;25:1068–1076.
    1. Benzoni O, Fàzzari G, Marangoni C, Placentino A, Rossi A. Treatment of resistant mood and schizoaffective disorders with electroconvulsive therapy: a case series of 264 patients. J Psychopathol. 2015;21:266–268.
    1. Zahid MA, Ohaeri JU. Schizophrenia psychopathology in a Kuwaiti Arab sample. Psychopathology. 2010;43:345–356.
    1. Guinchat V, Cravero C, Diaz L et al. . Acute behavioral crises in psychiatric inpatients with autism spectrum disorder (ASD): recognition of concomitant medical or non-ASD psychiatric conditions predicts enhanced improvement. Res Dev Disabil. 2015;38:242–255.
    1. Menard ML, Thümmler S, Auby P, Askenazy F. Preliminary and ongoing French multicenter prospective naturalistic study of adverse events of antipsychotic treatment in naive children and adolescents. Child Adolesc Psychiatry Ment Health. 2014;8:18.
    1. Medda P, Toni C, Luchini F, Giorgi Mariani M, Mauri M, Perugi G. Catatonia in 26 patients with bipolar disorder: clinical features and response to electroconvulsive therapy. Bipolar Disord. 2015;17:892–901.
    1. Takahashi N, Takahashi M, Saito T et al. . Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia. Neuropsychiatr Dis Treat. 2013;9:1889–1898.
    1. Grover S, Kate N, Gupta G. Use of electroconvulsive therapy in an adolescent patient with catatonia. Indian J Psychol Med. 2014;36:195–197.
    1. Jaimes-Albornoz W, Serra-Mestres J. Prevalence and clinical correlations of catatonia in older adults referred to a liaison psychiatry service in a general hospital. Gen Hosp Psychiatry. 2013;35:512–516.
    1. Nahar A, Kondapuram N, Desai G, Chandra PS. Catatonia among women with postpartum psychosis in a Mother-Baby inpatient psychiatry unit. Gen Hosp Psychiatry. 2017;45:40–43.
    1. Ishida T, Sakurai H, Watanabe K, Iwashita S, Mimura M, Uchida H. Incidence of deep vein thrombosis in catatonic patients: a chart review. Psychiatry Res. 2016;241:61–65.
    1. Kakooza-Mwesige A, Dhossche DM, Idro R, Akena D, Nalugya J, Opar BT. Catatonia in Ugandan children with nodding syndrome and effects of treatment with lorazepam: a pilot study. BMC Res Notes. 2015;8:825.
    1. Valencia M, Fresán A, Barak Y, Juárez F, Escamilla R, Saracco R. Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome. Neuropsychiatr Dis Treat. 2015;11:2339–2348.
    1. Espinola-Nadurille M, Ramirez-Bermudez J, Fricchione GL, Ojeda-Lopez MC, Perez-González AF, Aguilar-Venegas LC. Catatonia in Neurologic and Psychiatric Patients at a Tertiary Neurological Center. J Neuropsychiatry Clin Neurosci. 2016;28:124–130.
    1. Rajkumar RP. Recurrent unipolar mania: a comparative, cross-sectional study. Compr Psychiatry. 2016;65:136–140.
    1. Kaelle J, Abujam A, Ediriweera H, Macfarlane MD. Prevalence and symptomatology of catatonia in elderly patients referred to a consultation-liaison psychiatry service. Australas Psychiatry. 2016;24:164–167.
    1. Usman DM, Olubunmi OA, Taiwo O, Taiwo A, Rahman L, Oladipo A. Comparison of catatonia presentation in patients with schizophrenia and mood disorders in Lagos, Nigeria. Iran J Psychiatry. 2011;6:7–11.
    1. Cuevas-Esteban J, Iglesias-González M, Rubio-Valera M, Serra-Mestres J, Serrano-Blanco A, Baladon L. Prevalence and characteristics of catatonia on admission to an acute geriatric psychiatry ward. Prog Neuropsychopharmacol Biol Psychiatry. 2017;78:27–33.
    1. Smith JH, Smith VD, Philbrick KL, Kumar N. Catatonic disorder due to a general medical or psychiatric condition. J Neuropsychiatry Clin Neurosci. 2012;24:198–207.
    1. Fink M. Clinical practice to change with divorce of catatonia and schizophrenia. J Clin Psychopharmacol. 2013;33:287–288.
    1. Fink M, Taylor MA. Catatonia: subtype or syndrome in DSM?Am J Psychiatry. 2006;163:1875–1876.
    1. Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160:1233–1241.
    1. Northoff G. Neuroleptic malignant syndrome and catatonia: one entity or two?Biol Psychiatry. 1996;40:431–433.
    1. Lin CC, Hung YY, Tsai MC, Huang TL. Relapses and recurrences of catatonia: 30-case analysis and literature review. Compr Psychiatry. 2016;66:157–165.
    1. Cornic F, Consoli A, Tanguy ML et al. . Association of adolescent catatonia with increased mortality and morbidity: evidence from a prospective follow-up study. Schizophr Res. 2009;113:233–240.
    1. Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G. A clinical review of the treatment of catatonia. Front Psychiatry. 2014;5:181.
    1. Breen J, Hare DJ. The nature and prevalence of catatonic symptoms in young people with autism. J Intellect Disabil Res. 2017;61:580–593.
    1. Mazzone L, Postorino V, Valeri G, Vicari S. Catatonia in patients with autism: prevalence and management. CNS Drugs. 2014;28:205–215.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel